Seite 1 von 2
Neuester Beitrag: 10.09.20 14:13
|Eröffnet am:||13.01.12 17:05||von: Biotechspezi.||Anzahl Beiträge:||33|
|Neuester Beitrag:||10.09.20 14:13||von: Vassago||Leser gesamt:||6.007|
|Seite: < 1 | 2 >|
Zahlen für Q1/20
"The Company anticipates total net cash usage during 2020 in a range of approximately $9.0 million to $9.5 million."
"The Company's present capital resources are expected to fund its planned operations into the second quarter of 2021. Yield10's ability to continue operations after its current cash resources are exhausted depends on its ability to obtain additional financing, including public or private equity financing, secured or unsecured debt financing, and receipt of additional government research grants, as well as licensing or other collaborative arrangements."